AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31563357 — intervention group
Group type: EXPERIMENTAL
Intervention: Low volume (LV) resistance training (mean = 494 kg)
Number of subjects: 18
Study 31563357 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume (HV) resistance training (mean = 686 kg)
Number of subjects: 18
Study 31563357 — intervention group
Group type: EXPERIMENTAL
Intervention: Low volume (LV) resistance training
Number of subjects: 18
Study 31563357 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume (HV) resistance training
Number of subjects: 18
Study 31563357 — intervention group
Group type: COMPARATOR
Intervention: Low volume (LV) and High volume (HV) resistance training
Number of subjects: 18
Study 28935285 — intervention group
Group type: EXPERIMENTAL
Intervention: No pelvic examination
Number of subjects: 202
Study 28935285 — intervention group
Group type: COMPARATOR
Intervention: Pelvic examination
Number of subjects: 202
Study 26553190 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized 3% hypertonic saline (HS)
Number of subjects: 227
Study 26553190 — intervention group
Group type: COMPARATOR
Intervention: Nebulized normal saline (NS)
Number of subjects: 227
Study 23333254 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation ON
Number of subjects: 16
Study 23333254 — intervention group
Group type: COMPARATOR
Intervention: Deep brain stimulation OFF
Number of subjects: 16
Study 21614414 — intervention group
Group type: EXPERIMENTAL
Intervention: cilostazol 100 mg
Number of subjects: 111
Study 21614414 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 111
Study 18447840 — intervention group
Group type: EXPERIMENTAL
Intervention: nebivolol (5 mg)
Number of subjects: 34
Study 18447840 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol (50 mg)
Number of subjects: 34
Study 16685870 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated analysis of T1-weighted MR scans
Number of subjects: 47
Study 16685870 — intervention group
Group type: EXPERIMENTAL
Intervention: Projection eigencoordinates from T1-weighted MR scans
Number of subjects: 47
Study 16685870 — intervention group
Group type: EXPERIMENTAL
Intervention: Best linear model based on 10 eigenvectors + baseline MMSE
Number of subjects: 47
Study 12718508 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole capsules
Number of subjects: 6
Study 12718508 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin capsules
Number of subjects: 6
Study 12718508 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 6
Study 9928754 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil SR/trandolapril 120/0.5 mg o.d. (dose step 1)
Number of subjects: 254
Study 9928754 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil SR/trandolapril 180/1 mg o.d. (dose step 2)
Number of subjects: 254
Study 9928754 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil SR/trandolapril 180/2 mg o.d. (dose step 3)
Number of subjects: 254
Study 9928754 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil SR/trandolapril
Number of subjects: 254
Study 8601264 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs, sunscreens, topical and intra-lesional corticosteroids, antimalarials
Number of subjects: 0
Study 8601264 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids or immunosuppressants
Number of subjects: 0
Study 8601264 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone, methylprednisolone, cyclophosphamide
Number of subjects: 0
Study 8601264 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0
Study 8601264 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies
Number of subjects: 0
Study 8601264 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensives, cholesterol-lowering drugs, hypoglycemic agents
Number of subjects: 0
Study 2125646 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Enteral Nutrition (TEN) with a polymeric diet
Number of subjects: 29
Study 2125646 — intervention group
Group type: COMPARATOR
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 29
Study 2125646 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TEN and TPN)
Number of subjects: 29
Study 7471064 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoisocytidine (psi ICyd) administered via daily i.v. injection for 5 consecutive days
Number of subjects: 0
Study 29691618 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles tendon re-rupture cohort
Number of subjects: 20
Study 27355507 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention with workflow modification and adherence/retention package
Number of subjects: 0
Study 27355507 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 24857827 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg fluoxetine daily for 3 weeks
Number of subjects: 29
Study 24857827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 21083737 — intervention group
Group type: EXPERIMENTAL
Intervention: Ricinus communis solution (RC)
Number of subjects: 30
Study 21083737 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite 1%
Number of subjects: 30
Study 21083737 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 30
Study 21083737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucopren Soft (MS)
Number of subjects: 30
Study 21083737 — intervention group
Group type: EXPERIMENTAL
Intervention: Elite Soft Relining (ES)
Number of subjects: 30
Study 20404379 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg daily
Number of subjects: 5695
Study 20404379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5695
Study 18592368 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvisational music therapy
Number of subjects: 0
Study 18592368 — intervention group
Group type: COMPARATOR
Intervention: Play sessions with toys
Number of subjects: 0
Study 17361519 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinye Baidu Granule (JYBDG), one package three times a day for two weeks
Number of subjects: 240
Study 17361519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 240
Study 17361519 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinye Baidu Granule (JYBDG)
Number of subjects: 240
Study 12901890 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP-Sym patient-based symptom questionnaire
Number of subjects: 0
Study 12901890 — intervention group
Group type: EXPERIMENTAL
Intervention: Process-of-care measures
Number of subjects: 0
Study 12901890 — intervention group
Group type: COMPARATOR
Intervention: Traditional outcome measures
Number of subjects: 0
Study 10964043 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network approach using genetic algorithms with cascade correlation for diagnosis of delayed gastric emptying from electrogastrograms (EGGs)
Number of subjects: 152
Study 10964043 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural network approach using genetic algorithms with cascade correlation
Number of subjects: 152
Study 8641247 — intervention group
Group type: EXPERIMENTAL
Intervention: Blackcurrant-strawberry nectar (200 ml, twice daily for 4-5 weeks, vitamin C content approximately 70 mg/100 g)
Number of subjects: 60
Study 8641247 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 1727913 — intervention group
Group type: EXPERIMENTAL
Intervention: ICRF‐187 1,000 mg/m2 IV
Number of subjects: 150
Study 1727913 — intervention group
Group type: COMPARATOR
Intervention: Control regimen (fluorouracil 500 mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 500 mg/m2 every 21 days IV)
Number of subjects: 150
Study 1727913 — intervention group
Group type: COMPARATOR
Intervention: Control regimen
Number of subjects: 150
Study 6463391 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg b.i.d.
Number of subjects: 18
Study 6463391 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg b.i.d.
Number of subjects: 18
Study 6463391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol 5 mg b.i.d.
Number of subjects: 18
Study 6463391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 30256491 — intervention group
Group type: COMPARATOR
Intervention: 8-week sham acupuncture treatment
Number of subjects: 124
Study 29716940 — intervention group
Group type: EXPERIMENTAL
Intervention: Bococizumab with statin therapy
Number of subjects: 9738
Study 26856210 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivessel intervention during index PCI
Number of subjects: 50632
Study 26856210 — intervention group
Group type: COMPARATOR
Intervention: Culprit-only intervention during index PCI
Number of subjects: 50632
Study 24675775 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein enriched egg
Number of subjects: 100
Study 24675775 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg-yolk based beverage
Number of subjects: 100
Study 24675775 — intervention group
Group type: EXPERIMENTAL
Intervention: Zeaxanthin enriched egg
Number of subjects: 100
Study 24675775 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal egg
Number of subjects: 100
Study 24675775 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary modification)
Number of subjects: 100
Study 23003106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 8
Study 23003106 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 8
Study 23003106 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 8
Study 20075335 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee consumption (caffeic acid and ferulic acid)
Number of subjects: 8
Study 20075335 — intervention group
Group type: COMPARATOR
Intervention: Water consumption (control)
Number of subjects: 8
Study 20075335 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferulic acid
Number of subjects: 8
Study 17765133 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Phone-Based Remote Patient Monitoring System
Number of subjects: 33
Study 15673327 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet (30 to 180 mg/day)
Number of subjects: 1136
Study 12055570 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EAR)
Number of subjects: 0
Study 12055570 — intervention group
Group type: COMPARATOR
Intervention: Conventional transabdominal surgery
Number of subjects: 0
Study 9841849 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine plus saquinavir
Number of subjects: 144
Study 9841849 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine and zalcitabine plus saquinavir
Number of subjects: 144
Study 9841849 — intervention group
Group type: COMPARATOR
Intervention: Comparison of two-drug vs three-drug combination
Number of subjects: 144
Study 9841849 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HIV RNA levels
Number of subjects: 144
Study 9841849 — intervention group
Group type: EXPERIMENTAL
Intervention: Codon 215 mutations
Number of subjects: 144
Study 7744136 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithotomy position with elevation of the legs
Number of subjects: 10
Study 7744136 — intervention group
Group type: COMPARATOR
Intervention: Lithotomy position without elevation of the legs
Number of subjects: 10
Study 2249070 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 155
Study 2249070 — intervention group
Group type: COMPARATOR
Intervention: Intravenous urography
Number of subjects: 155
Study 7193307 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa administered by mouth
Number of subjects: 12
Study 7193307 — intervention group
Group type: COMPARATOR
Intervention: Levodopa administered rectally
Number of subjects: 12
Study 30761530 — intervention group
Group type: EXPERIMENTAL
Intervention: RM-CPAP group
Number of subjects: 60
Study 30761530 — intervention group
Group type: COMPARATOR
Intervention: ZEEP group
Number of subjects: 60
Study 30761530 — intervention group
Group type: COMPARATOR
Intervention: RM group
Number of subjects: 60
Study 29145211 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 therapy
Number of subjects: 386
Study 29145211 — intervention group
Group type: COMPARATOR
Intervention: Taxane
Number of subjects: 386
Study 26802300 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ankle movement (30 times/min, 1‐7 days after surgery)
Number of subjects: 174
Study 24103395 — intervention group
Group type: EXPERIMENTAL
Intervention: Dr Atkins' New Diet Revolution
Number of subjects: 287
Study 24103395 — intervention group
Group type: EXPERIMENTAL
Intervention: The Slim‐Fast Plan
Number of subjects: 287
Study 24103395 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight‐Watchers programme
Number of subjects: 287
Study 24103395 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosemary Conley's Diet and Fitness Plan
Number of subjects: 287
Study 24103395 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 287
Study 22143488 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Treatment (adapted for prevention of depression)
Number of subjects: 93
Study 19766972 — intervention group
Group type: EXPERIMENTAL
Intervention: Many alternatives differentiated on many attributes
Number of subjects: 0
Study 19766972 — intervention group
Group type: COMPARATOR
Intervention: Many alternatives differentiated on few attributes
Number of subjects: 0
Study 17400086 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO) 600 IU/kg once weekly for 4 doses
Number of subjects: 251
Study 17400086 — intervention group
Group type: COMPARATOR
Intervention: Preoperative autologous donation (PAD)
Number of subjects: 251
Study 17400086 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO)
Number of subjects: 251
Study 15877947 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive treatment based on traditional Chinese medical differentiation
Number of subjects: 522
Study 15877947 — intervention group
Group type: COMPARATOR
Intervention: General treatment
Number of subjects: 522
Study 15877947 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 522
Study 15877947 — intervention group
Group type: COMPARATOR
Intervention: Western medicine treatment
Number of subjects: 522
Study 12471536 — intervention group
Group type: EXPERIMENTAL
Intervention: Angled swing‐jaw forceps
Number of subjects: 48
Study 12471536 — intervention group
Group type: COMPARATOR
Intervention: Large cup disposable forceps
Number of subjects: 48
Study 12471536 — intervention group
Group type: COMPARATOR
Intervention: Conventional reusable upper gastrointestinal forceps
Number of subjects: 48
Study 10355005 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on decreasing frequent and prolonged feeding with a nursing bottle and other sugar containing foods, daily brushing with 0.4% SnF2 gel, and additional training sessions for one caretaker.
Number of subjects: 3
Study 10355005 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly topical fluoride treatments with 2% NaF for two children.
Number of subjects: 3
Study 8633913 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-sparing therapy group
Number of subjects: 678
Study 8633913 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional therapy)
Number of subjects: 678
Study 1769603 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine (used only if diastolic pressure of 110 mmHg or more)
Number of subjects: 38
Study 1769603 — intervention group
Group type: COMPARATOR
Intervention: Hydralazine 40 mg per os every 6 hrs, plus sublingual nifedipine (used if diastolic pressure of 110 mmHg or more)
Number of subjects: 38
Study 6121090 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 60
Study 6121090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30762655 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC of the placenta
Number of subjects: 30
Study 30762655 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC of the fetal brain
Number of subjects: 30
Study 30762655 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC of the fetal lung
Number of subjects: 30
Study 30762655 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC of the fetal kidney
Number of subjects: 30
Study 30762655 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ADC of the placenta and fetal organs
Number of subjects: 30
Study 30762655 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ADC of the placenta and fetal brain
Number of subjects: 30
Study 25389072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic preconditioning (3 cycles of 5-min upper arm cuff inflation to 220 mmHg)
Number of subjects: 30
Study 25389072 — intervention group
Group type: COMPARATOR
Intervention: No ischaemic preconditioning (no inflation)
Number of subjects: 30
Study 24661333 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix 80 mg
Number of subjects: 385
Study 24661333 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix 160 mg
Number of subjects: 385
Study 24661333 — intervention group
Group type: COMPARATOR
Intervention: Degarelix 240/80 mg (crossover from leuprolide)
Number of subjects: 385
Study 24661333 — intervention group
Group type: COMPARATOR
Intervention: Degarelix 240/160 mg (crossover from leuprolide)
Number of subjects: 385
Study 24661333 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix (continuation)
Number of subjects: 385
Study 22161728 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg annually for 6 years (Z6, n = 616)
Number of subjects: 1233
Study 22161728 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Z3P3, n = 617)
Number of subjects: 1233
Study 22161728 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg annually for 6 years (Z6)
Number of subjects: 1233
Study 22161728 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Z3P3)
Number of subjects: 1233
Study 19786251 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm of 2 prospective randomized studies
Number of subjects: 120
Study 17996075 — intervention group
Group type: EXPERIMENTAL
Intervention: Iyengar yoga class with home practice
Number of subjects: 135
Study 17996075 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise class with home practice
Number of subjects: 135
Study 17996075 — intervention group
Group type: COMPARATOR
Intervention: wait-list control group
Number of subjects: 135
Study 15911864 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 293
Study 15911864 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin with topotecan (CT)
Number of subjects: 293
Study 15911864 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline FACT-G
Number of subjects: 293
Study 15911864 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline BPI
Number of subjects: 293
Study 15911864 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline UNI
Number of subjects: 293
Study 15911864 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline FACT-Cx
Number of subjects: 293
Study 12198987 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% carbamide peroxide and 0.11% fluoride ion gel
Number of subjects: 100
Study 12198987 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 100
Study 11271692 — intervention group
Group type: EXPERIMENTAL
Intervention: Education about the use, storage and nutritional value of fruits and vegetables
Number of subjects: 564
Study 11271692 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution of farmers' market coupons
Number of subjects: 564
Study 11271692 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of education and coupons
Number of subjects: 564
Study 11271692 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 564
Study 11271692 — intervention group
Group type: COMPARATOR
Intervention: Coupons only
Number of subjects: 564
Study 9755033 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Hz magnetic field exposure (20 microT, 200 mG)
Number of subjects: 30
Study 9755033 — intervention group
Group type: COMPARATOR
Intervention: Sham-exposure
Number of subjects: 30
Study 9755033 — intervention group
Group type: EXPERIMENTAL
Intervention: Square-wave currents
Number of subjects: 30
Study 9755033 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoidal waveforms
Number of subjects: 30
Study 7819079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound imaging
Number of subjects: 47
Study 7819079 — intervention group
Group type: COMPARATOR
Intervention: Conventional staging (physical examination, laryngoscopy, CT of thorax and abdomen, bone marrow cytology and histology)
Number of subjects: 47
Study 3388475 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP (300 micrograms)
Number of subjects: 0
Study 3388475 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Citrated Plasma)
Number of subjects: 0
Study 3388475 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Heparinized Plasma)
Number of subjects: 0
Study 8087516 — intervention group
Group type: EXPERIMENTAL
Intervention: CHART regime (Continuous, Hyperfractionated, Accelerated Radiotherapy)
Number of subjects: 300
Study 8087516 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (60 Gy in 6 weeks)
Number of subjects: 300
Study 350251 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sodium valproate (800 mg)
Number of subjects: 6
Study 350251 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium valproate (800 mg)
Number of subjects: 6
Study 350251 — intervention group
Group type: COMPARATOR
Intervention: Comparison with healthy volunteers
Number of subjects: 6
Study 31619057 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous busulfan (BU) pre-transplant
Number of subjects: 13
Study 30102174 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention with up to ten sessions with a peer support worker who assisted in completing a personal recovery workbook.
Number of subjects: 441
Study 30102174 — intervention group
Group type: COMPARATOR
Intervention: Control group received the personal recovery workbook by post.
Number of subjects: 441
Study 30102174 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support intervention
Number of subjects: 441
Study 30102174 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 441